STAND. COM. REP. NO.  430-18

 

Honolulu, Hawaii

                , 2018

 

RE:   H.B. No. 2531

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

 

Sir:

 

     Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 2531, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"

 

begs leave to report as follows:

 

     The purpose of this measure is to address drug overdose rates in the State by requiring prescribers to consult the state electronic prescription accountability system before issuing a prescription for Schedule II, III, or IV controlled substances.

 

     The Department of Health, Department of Public Safety, and Hawaii Medical Service Association testified in support of this measure.

 

     As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2531, H.D. 1, and recommends that it be referred to your Committee on Judiciary.

 

 

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

 

 

 

 

____________________________

ROY M. TAKUMI, Chair